Wall Street Journal - Thomas Gryta - 21 hours ago
In October, Amgen received a complete response letter from the FDA, seeking more information and delaying the approval for the drug's use in osteoporosis ...
Further key projects in clinical development comprise the three orally administered compounds TASQ for prostate cancer, 57-57 for SLE and RhuDex™ for RA. ...
Doctors are currently using the system for ablation of brain, prostate, liver, bone, and other solid tumors. For more information about the Visualase ...
... molecular diagnostic test for colon cancer, Health Discovery Corporation employed the same discovery process that led to the urine-based prostate cancer...
For more information on prostate cancer, visit the Prostate Cancer Foundation Web site. For more information on Gossett, his memoir, An Actor and a ...
Man to Man, a support group for prostate cancer survivors. Personal health manager, an informational package including valuable resource information. ...
This capability will take prostate cancer diagnosis and treatment to an exciting new level. Once the combined technologies are clinically validated, ...
The site includes basic information about prostate cancer, resources for caregivers and information on clinical trials. Visit the site to read the stories ...
OurSports Central (press release) - 16 hours ago
(Boise, ID) - The ECHL's Idaho Steelheads and St. Luke's Health System have joined forces for the Prostate Cancer Awareness jersey auction during this ...
In 2008, it was revealed at an FDA advisory committee meeting that GPC Biotech had misrepresented the SPA for its prostate cancer drug, causing shares to ...
Email this story
